Skites Pharma Private Limited

Pharma and healthcare distribution company providing trade and B2B distribution, hospital supplies, and direct-to-patient services.

2017 | Mumbai, Maharashtra (India) | Active
Last Updated:

Skites Pharma Profile

Key Indicators

  • Authorised Capital ₹ 7.00 Cr
  • Paid Up Capital ₹ 5.94 Cr
  • Company Age 8 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 79.92 Cr
  • Revenue Growth 39.55%
  • Profit Growth 0.50%
  • Ebitda 427.49%
  • Net Worth -13.56%
  • Total Assets 38.53%

About Skites Pharma

Skites Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 March 2017 (Eight years and one month 17 days old ). Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 5.94 Cr.

The company currently has active open charges totaling ₹79.92 Cr.

Samir Shah, Mahesh Shah, Rohan Shah, and One other member serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24304MH2017PTC292537

  • Company No.

    292537

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    16 Mar 2017

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Skites Pharma Private Limited offer?

Skites Pharma Private Limited offers a wide range of products and services, including Disposable & Other Optical Lenses, Contact Lens Accessories.

Company report

Skites Pharma Private Limited

Explore comprehensive data for Skites Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Skites Pharma?

Board Members (4)

NameDesignationAppointment DateStatus
Rohan Shah Country flag representing In Director 16-Mar-2017Current
Samir Shah Country flag representing In Director 16-Mar-2017Current
Mahesh Shah Country flag representing In Director 13-Feb-2018Current
Eishi Maekawa Country flag representing Jp Director 16-Jul-2021Current

Financial Performance of Skites Pharma.

Skites Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.55% increase. The company also saw a slight improvement in profitability, with a 0.5% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.56%.

Skites Pharma revenue growth over time
Skites Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
39.55%
Revenue from Operations
39.54%
Total Assets
38.53%
Profit or Loss
0.50%
Net Worth
-13.56%
EBITDA
427.49%

What is the Ownership and Shareholding Structure of Skites Pharma?

In 2023, Skites Pharma had a promoter holding of 100.00%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹79.92 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 79.92 Cr

Latest Charge Details

DateLenderAmountStatus
22 Jun 2018Hdfc Bank Limited₹79.92 CrOpen

How Many Employees Work at Skites Pharma?

Skites Pharma has a workforce of 459 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Skites Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Skites Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skites Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Skites Pharma

Recent activity within the organization

  • Annual General Meeting

    Skites Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Skites Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 79.92 Cr registered on 22 Jun 2018 with Charge ID 100194077 was modified on 22 Jul 2022.

  • Director Appointment

    Eishi Maekawa was appointed as a Director was appointed as a Director on 16 Jul 2021 & has been associated with this company since 3 years 9 months .

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 79.92 Cr with Charge ID 100194077 was registered on 22 Jun 2018.

  • Director Appointment

    Mahesh Kantilal Shah was appointed as a Director was appointed as a Director on 13 Feb 2018 & has been associated with this company since 7 years 2 months .

Frequently asked questions

  • What is the Incorporation or founding date of Skites Pharma Private Limited?

    Skites Pharma Private Limited was incorporated on 16 Mar 2017.

  • What is authorized share capital and paid-up capital of Skites Pharma Private Limited?

    The authorized share capital of Skites Pharma Private Limited is ₹ 7.00 Cr and paid-up capital is ₹ 5.94 Cr.

  • Who are the current board members & directors of Skites Pharma Private Limited?

    Currently 4 directors are associated with Skites Pharma Private Limited.

    • Samir Jayantilal Shah
    • Mahesh Kantilal Shah
    • Rohan Mahesh Shah
    • Eishi Maekawa
  • What is the registered address of Skites Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Skites Pharma Private Limited is Flr-G 15 Mehta Mahal P L Khandke Marg Mathew Road Opera House, Girgaon India, Mumbai, Maharashtra, 400004.

  • What is the corporate identification number (CIN) and company number of Skites Pharma Private Limited?

    The corporate identification number (CIN) of Skites Pharma Private Limited is U24304MH2017PTC292537 and the company number is 292537 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Skites Pharma Private Limited?

    The Official website of Skites Pharma Private Limited is https://www.skitespharma.com

  • What has been the recent revenue trend for Skites Pharma Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Skites Pharma Private Limited has risen by 39.55%.

  • How many employees does Skites Pharma Private Limited currently have?

    As Per 2023 financial reports, 459 employees are currently employed by Skites Pharma Private Limited.

  • What change has been observed in the net worth of Skites Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Skites Pharma Private Limited has experienced an downturn of -13.56%.

  • What are the total open charges for Skites Pharma Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Skites Pharma Private Limited amount to ₹ 79.92 Cr.

  • When was the last Balance Sheet of Skites Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Skites Pharma Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial